Gossamer Bio GOSS
NASDAQ GOSS
$0.16 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) EBT Margin (2024 - 2026)

Gossamer Bio (GOSS) posted quarterly EBT Margin of 295.38% for Q1 2026, up 10165.0% year-over-year from N/an in Q1 2025, and up 13.87% quarter-over-quarter from 342.97% in Q4 2025.

Gossamer Bio (GOSS) EBT Margin (2024 - 2026) Analysis & Trends

Gossamer Bio's EBT Margin history runs 3 years deep, the most recent figure standing at 295.38% for Q1 2026.

  • In Q1 2026, EBT Margin rose 10165.0% year-over-year to 295.38%; the TTM figure through Mar 2026 stood at 331.13% (down 27848.0% YoY), while the FY2025 annual figure was 351.67%, down 29033.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 295.38%, up from 342.97% in the prior quarter.
  • The five-year high for EBT Margin was 242.37% in Q4 2024, with the low at 397.03% in Q1 2025.
  • The 3-year median for EBT Margin is 335.0% (2024), against an average of 221.22%.
  • The sharpest annual moves came in 2025 and 2026: EBT Margin plunged 58533 bps in 2025, then surged 10165 bps in 2026.
  • Gossamer Bio's EBT Margin stood at 242.37% in 2024, then plunged by 242 bps to 342.97% in 2025, then gained by 14 bps to 295.38% in 2026.
  • Business Quant data shows GOSS's EBT Margin at 295.38% in Q1 2026, 342.97% in Q4 2025, and 362.73% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 35.61%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 35.71%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -528.97%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 13.77%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -2.67%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -25.06%
10 Gossamer Bio 50.34 Mn -6.69 Mn - -308.63%

Historic Data

Download Data
DateValue
Jun 30, 2026 -331.08%
Mar 31, 2026 -295.38%
Dec 31, 2025 -342.97%
Sep 30, 2025 -362.73%
Jun 30, 2025 -333.13%
Mar 31, 2025 -397.03%
Dec 31, 2024 242.37%
Sep 30, 2024 -336.87%
Jun 30, 2024 56.00%